China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 21.93
-0.39 (-1.75%)
At close: Feb 13, 2026
SHE:300294 Market Cap
SHE:300294 has a market cap or net worth of 11.06 billion as of February 13, 2026. Its market cap has decreased by -24.38% in one year.
Market Cap
11.06B
Enterprise Value
7.95B
Revenue
1.96B
Ranking
n/a
PE Ratio
33.73
Stock Price
21.93
Market Cap Chart
Since March 8, 2012, SHE:300294's market cap has increased from 2.94B to 11.06B, an increase of 276.00%. That is a compound annual growth rate of 9.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 11.06B | -2.96% |
| Dec 31, 2025 | 11.40B | -25.36% |
| Dec 31, 2024 | 15.27B | -10.10% |
| Dec 29, 2023 | 16.98B | -7.88% |
| Dec 30, 2022 | 18.44B | -4.67% |
| Dec 31, 2021 | 19.34B | 35.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Hotgen Biotech | 12.28B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.03B |
| HitGen | 11.76B |
| Vcanbio Cell & Gene Engineering Corp., | 11.60B |
| Chengdu Easton Biopharmaceuticals | 11.23B |
| Aurisco Pharmaceutical | 10.94B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.68B |
| Liaoning Chengda Biotechnology | 10.62B |